Geode Capital Management’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$114K Buy
94,287
+28,284
+43% +$35.4K ﹤0.01% 4100
2025
Q4
$82.5K Buy
66,003
+27,263
+70% +$37K ﹤0.01% 4140
2025
Q3
$50K Buy
38,740
+1,277
+3% +$2.5K ﹤0.01% 4293
2025
Q2
$73.1K Buy
37,463
+232
+0.6% +$516 ﹤0.01% 4143
2025
Q1
$94.6K Buy
37,231
+6,244
+20% +$15.1K ﹤0.01% 4045
2024
Q4
$67.5K Buy
30,987
+16,251
+110% +$38.1K ﹤0.01% 4188
2024
Q3
$46K Buy
14,736
+1,715
+13% +$4.93K ﹤0.01% 4276
2024
Q2
$38.7K Buy
13,021
+2,630
+25% +$13.2K ﹤0.01% 4331
2024
Q1
$63.4K Sell
10,391
-252
-2% -$1.81K ﹤0.01% 4269
2023
Q4
$106K Buy
10,643
+966
+10% +$7.84K ﹤0.01% 4173
2023
Q3
$62K Hold
9,677
﹤0.01% 4371
2023
Q2
$388K Buy
9,677
+3,237
+50% +$99.7K ﹤0.01% 3745
2023
Q1
$189K Hold
6,440
﹤0.01% 4080
2022
Q4
$201K Buy
6,440
+261
+4% +$7.42K ﹤0.01% 4096
2022
Q3
$179K Buy
6,179
+88
+1% +$2.28K ﹤0.01% 4276
2022
Q2
$135K Buy
6,091
+254
+4% +$6.08K ﹤0.01% 4456
2022
Q1
$181K Buy
5,837
+715
+14% +$21.2K ﹤0.01% 4427
2021
Q4
$149K Hold
5,122
﹤0.01% 4596
2021
Q3
$241K Hold
5,122
﹤0.01% 4357
2021
Q2
$304K Buy
5,122
+977
+24% +$59.3K ﹤0.01% 4162
2021
Q1
$269K Buy
4,145
+2,641
+176% +$165K ﹤0.01% 4024
2020
Q4
$78K Buy
+1,504
New +$60.1K ﹤0.01% 4098

Other funds holding BCDA

Geode Capital Management's BCDA Position: Q1 2026 in Review

Geode Capital Management increased its BioCardia (BCDA) stake by 43% in Q1 2026, buying an estimated $35.4K and bringing the position to 94,287 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #4100.

Geode Capital Management first reported a position in BCDA in Q4 2020 and has held it in 22 quarters since. The position peaked at $388K in Q2 2023. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • Geode Capital Management held 94,287 shares of BioCardia worth $114K as of Q1 2026.
  • Geode Capital Management bought 28,284 BioCardia shares in Q1 2026, an estimated $35.4K.
  • BioCardia made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4100 holding.
  • Geode Capital Management first reported a position in BioCardia in Q4 2020 and has held it in 22 quarters since.
  • Geode Capital Management's BioCardia position peaked at $388K in Q2 2023.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.